BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu X, Kumar R, Mandal M, Sharma N, Sharma HW, Dhingra U, Sokoloski JA, Hsiao R, Narayanan R. Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci U S A 1996;93:6091-5. [PMID: 8650224 DOI: 10.1073/pnas.93.12.6091] [Cited by in Crossref: 152] [Cited by in F6Publishing: 155] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Sharma S, Raymond E, Soda H, Izbicka E, Davidson K, Lawrence R, Von Hoff DD. Dimethyl sulfoxide (DMSO) causes a reversible inhibition of telomerase activity in a Burkitt lymphoma cell line. Leukemia Research 1998;22:663-70. [DOI: 10.1016/s0145-2126(97)00188-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
2 Funakoshi Y, Nakayama H, Uetsuka K, Nishimura R, Sasaki N, Doi K. Cellular proliferative and telomerase activity in canine mammary gland tumors. Vet Pathol 2000;37:177-83. [PMID: 10714647 DOI: 10.1354/vp.37-2-177] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
3 Tomlinson RL, Ziegler TD, Supakorndej T, Terns RM, Terns MP. Cell cycle-regulated trafficking of human telomerase to telomeres. Mol Biol Cell 2006;17:955-65. [PMID: 16339074 DOI: 10.1091/mbc.e05-09-0903] [Cited by in Crossref: 186] [Cited by in F6Publishing: 143] [Article Influence: 10.9] [Reference Citation Analysis]
4 Harada K, Kurisu K, Sadatomo T, Tahara H, Tahara E, Ide T, Tahara E. Growth inhibition of human glioma cells by transfection-induced P21 and its effects on telomerase activity. J Neurooncol. 2000;47:39-46. [PMID: 10930098 DOI: 10.1023/a:1006428529637] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Shen T, Ma J, Zhang L, Yu X, Liu M, Hou Y, Wang Y, Ma C, Li S, Zhu D. Positive feedback-loop of telomerase reverse transcriptase and 15-lipoxygenase-2 promotes pulmonary hypertension. PLoS One 2013;8:e83132. [PMID: 24376652 DOI: 10.1371/journal.pone.0083132] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
6 Hu BT, Insel RA. Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit. Eur J Immunol 1999;29:3745-53. [DOI: 10.1002/(sici)1521-4141(199911)29:11<3745::aid-immu3745>3.0.co;2-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sawa H, Kamada H, Ohshima TA, Noguchi A, Itoh N, Saruta K, Hara M, Saito I. Exogenous expression of p16INK4a is associated with decrease in telomerase activity. J Neurooncol 1999;42:45-57. [PMID: 10360478 DOI: 10.1023/a:1006176708928] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
8 Ji X, Sun H, Zhou H, Xiang J, Tang Y, Zhao C. The interaction of telomeric DNA and C-myc22 G-quadruplex with 11 natural alkaloids. Nucleic Acid Ther 2012;22:127-36. [PMID: 22480315 DOI: 10.1089/nat.2012.0342] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
9 Cassar L, Li H, Jiang FX, Liu JP. TGF-beta induces telomerase-dependent pancreatic tumor cell cycle arrest. Mol Cell Endocrinol 2010;320:97-105. [PMID: 20138964 DOI: 10.1016/j.mce.2010.02.002] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
10 Crowe DL, Nguyen DC, Tsang KJ, Kyo S. E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res 2001;29:2789-94. [PMID: 11433024 DOI: 10.1093/nar/29.13.2789] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 4.8] [Reference Citation Analysis]
11 Tuma RS, Beaudet MP, Jin X, Jones LJ, Cheung C, Yue S, Singer VL. Characterization of SYBR Gold Nucleic Acid Gel Stain: A Dye Optimized for Use with 300-nm Ultraviolet Transilluminators. Analytical Biochemistry 1999;268:278-88. [DOI: 10.1006/abio.1998.3067] [Cited by in Crossref: 203] [Cited by in F6Publishing: 168] [Article Influence: 8.8] [Reference Citation Analysis]
12 Vignoli M, Stecca B, Furlini G, Re MC, Mantovani V, Zauli G, Visani G, Colangeli V, La Placa M. Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients: . AIDS 1998;12:999-1005. [DOI: 10.1097/00002030-199809000-00006] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
13 Bae-Jump VL, Zhou C, Gehrig PA, Whang YE, Boggess JF. Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest. Gynecol Oncol 2006;100:487-94. [PMID: 16249016 DOI: 10.1016/j.ygyno.2005.08.053] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
14 Shiratsuch M, Muta K, Umemura T, Nishimura J, Nawata H, Kozuru M. Telomerase Activity in Myeloma Cells is Closely Related to Cell Cycle Status, but not to Apoptotic Signals Induced by Interferon-α. Leukemia & Lymphoma 2009;34:349-59. [DOI: 10.3109/10428199909050960] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
15 Järås M, Edqvist A, Rebetz J, Salford LG, Widegren B, Fan X. Human short-term repopulating cells have enhanced telomerase reverse transcriptase expression. Blood 2006;108:1084-91. [DOI: 10.1182/blood-2005-09-008904] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
16 Rufer N, Dragowska W, Thornbury G, Roosnek E, Lansdorp PM. Telomere length dynamics in human lymphocyte subpopulations measured by flow cytometry. Nat Biotechnol 1998;16:743-7. [DOI: 10.1038/nbt0898-743] [Cited by in Crossref: 392] [Cited by in F6Publishing: 368] [Article Influence: 16.3] [Reference Citation Analysis]
17 Webb CJ, Wu Y, Zakian VA. DNA repair at telomeres: keeping the ends intact. Cold Spring Harb Perspect Biol 2013;5:a012666. [PMID: 23732473 DOI: 10.1101/cshperspect.a012666] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
18 Schaheen L, Dang H, Fares H. Basis of lethality in C. elegans lacking CUP-5, the Mucolipidosis Type IV orthologue. Dev Biol 2006;293:382-91. [PMID: 16530747 DOI: 10.1016/j.ydbio.2006.02.008] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
19 Zheng KW, Liu C, Meng Q, Hao YH, Zheng JP, Li W, Tan Z. One-Step High-Throughput Telomerase Activity Measurement of Cell Populations, Single Cells, and Single-Enzyme Complexes. ACS Omega 2020;5:24666-73. [PMID: 33015483 DOI: 10.1021/acsomega.0c03246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Sriwilaijareon N, Petmitr S, Mutirangura A, Ponglikitmongkol M, Wilairat P. Stage specificity of Plasmodium falciparum telomerase and its inhibition by berberine. Parasitology International 2002;51:99-103. [DOI: 10.1016/s1383-5769(01)00092-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
21 Nguyen DC, Crowe DL. Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1999;1445:207-15. [DOI: 10.1016/s0167-4781(99)00044-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
22 Georgiou CD, Papapostolou I. Assay for the quantification of intact/fragmented genomic DNA. Anal Biochem 2006;358:247-56. [PMID: 16942746 DOI: 10.1016/j.ab.2006.07.035] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
23 Radak Z, Taylor A, Sasvari M, Ohno H, Horkay B, Furesz J, Gaal D, Kanel T. Telomerase activity is not altered by regular strenuous exercise in skeletal muscle or by sarcoma in liver of rats. Redox Report 2013;6:99-103. [DOI: 10.1179/135100001101536102] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
24 Li H, Zhao L, Funder JW, Liu J. Protein Phosphatase 2A Inhibits Nuclear Telomerase Activity in Human Breast Cancer Cells. Journal of Biological Chemistry 1997;272:16729-32. [DOI: 10.1074/jbc.272.27.16729] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 5.2] [Reference Citation Analysis]
25 Kruk PA, Orren DK, Bohr VA. Telomerase activity is elevated in early S phase in hamster cells. Biochem Biophys Res Commun 1997;233:717-22. [PMID: 9168921 DOI: 10.1006/bbrc.1997.6549] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
26 Shao JC, Wu JF, Wang DB, Qin R, Zhang H. Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance. World J Gastroenterol 2003; 9(3): 427-431 [PMID: 12632490 DOI: 10.3748/wjg.v9.i3.427] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
27 Samad MA, Saiman MZ, Abdul Majid N, Karsani SA, Yaacob JS. Berberine Inhibits Telomerase Activity and Induces Cell Cycle Arrest and Telomere Erosion in Colorectal Cancer Cell Line, HCT 116. Molecules 2021;26:E376. [PMID: 33450878 DOI: 10.3390/molecules26020376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Bhagwandin VJ, Shay JW. Pancreatic cancer stem cells: fact or fiction? Biochim Biophys Acta 2009;1792:248-59. [PMID: 19233264 DOI: 10.1016/j.bbadis.2009.02.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
29 Wu K, Orme LM, Shaughnessy J, Jacobson J, Barlogie B, Moore MAS. Telomerase and telomere length in multiple myeloma: correlations with disease heterogeneity, cytogenetic status, and overall survival. Blood 2003;101:4982-9. [DOI: 10.1182/blood-2002-11-3451] [Cited by in Crossref: 80] [Cited by in F6Publishing: 70] [Article Influence: 4.2] [Reference Citation Analysis]
30 Tanemura K, Ogura A, Cheong C, Gotoh H, Matsumoto K, Sato E, Hayashi Y, Lee H, Kondo T. Dynamic rearrangement of telomeres during spermatogenesis in mice. Developmental Biology 2005;281:196-207. [DOI: 10.1016/j.ydbio.2005.02.025] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
31 Edqvist A, Rebetz J, Järås M, Rydelius A, Skagerberg G, Salford LG, Widegren B, Fan X. Detection of cell cycle- and differentiation stage-dependent human telomerase reverse transcriptase expression in single living cancer cells. Molecular Therapy 2006;14:139-48. [DOI: 10.1016/j.ymthe.2005.12.018] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
32 Zhao YM, Zhou Q, Xu Y, Lai XY, Huang H. Antiproliferative effect of rapamycin on human T-cell leukemia cell line Jurkat by cell cycle arrest and telomerase inhibition. Acta Pharmacol Sin 2008;29:481-8. [PMID: 18358095 DOI: 10.1111/j.1745-7254.2008.00767.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.7] [Reference Citation Analysis]
33 Qin Q, Wang S, Tan M, Wang Z, Huang X, Wei Q, Shi B, Zou B, Liang H. Synthesis and antitumor mechanisms of two novel platinum( ii ) complexes with 3-(2′-benzimidazolyl)-7-methoxycoumarin. Metallomics 2018;10:1160-9. [DOI: 10.1039/c8mt00125a] [Cited by in Crossref: 25] [Cited by in F6Publishing: 2] [Article Influence: 6.3] [Reference Citation Analysis]
34 Salehinejad P, Alitheen NB, Mandegary A, Nematollahi-mahani SN, Janzamin E. Effect of EGF and FGF on the expansion properties of human umbilical cord mesenchymal cells. In Vitro Cell Dev Biol -Animal 2013;49:515-23. [DOI: 10.1007/s11626-013-9631-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
35 Sato N, Mizumoto K, Kusumoto M, Nishio S, Maehara N, Urashima T, Ogawa T, Tanaka M. Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide. Br J Cancer 2000;82:1819-26. [PMID: 10839297 DOI: 10.1054/bjoc.2000.1117] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
36 Katakura Y, Yamamoto K, Miyake O, Yasuda T, Uehara N, Nakata E, Kawamoto S, Shirahata S. Bidirectional Regulation of Telomerase Activity in a Subline Derived from Human Lung Adenocarcinoma. Biochemical and Biophysical Research Communications 1997;237:313-7. [DOI: 10.1006/bbrc.1997.7104] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
37 Yang Y, Bin YD, Qin QP, Luo XJ, Zou BQ, Zhang HX. Novel Quinoline-based Ir(III) Complexes Exhibit High Antitumor Activity in Vitro and in Vivo. ACS Med Chem Lett 2019;10:1614-9. [PMID: 31857836 DOI: 10.1021/acsmedchemlett.9b00337] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
38 Liu JY, Zhu Q, Li J, Zhao S, Li L. The retrovirus-mediated antisense human telomerase RNA (hTR) gene limits the growth of hepatocellular carcinoma growth in cell culture and animals. Dig Dis Sci 2008;53:1122-30. [PMID: 17932748 DOI: 10.1007/s10620-007-9980-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
39 Zou H, Wei J, Qin X, Mo S, Qin Q, Liu Y, Liang F, Zhang Y, Chen Z. Synthesis, crystal structure, cytotoxicity and action mechanism of Zn( ii ) and Mn( ii ) complexes with 4-([2,2′:6′,2′′-terpyridin]-4′-yl)-N,N-diethylaniline as a ligand. Med Chem Commun 2016;7:1132-7. [DOI: 10.1039/c6md00098c] [Cited by in Crossref: 7] [Article Influence: 1.2] [Reference Citation Analysis]
40 Crowe DL, Nguyen DC. Rb and E2F-1 regulate telomerase activity in human cancer cells. Biochim Biophys Acta 2001;1518:1-6. [PMID: 11267653 DOI: 10.1016/s0167-4781(00)00296-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
41 Bae-Jump VL, Zhou C, Boggess JF, Whang YE, Barroilhet L, Gehrig PA. Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment. Gynecol Oncol 2010;119:579-85. [PMID: 20863555 DOI: 10.1016/j.ygyno.2010.08.025] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
42 Nolte J. Lrrc34 Interacts with Oct4 and Has an Impact on Telomere Length in Mouse Embryonic Stem Cells. Stem Cells Dev 2021;30:1093-102. [PMID: 34549596 DOI: 10.1089/scd.2021.0113] [Reference Citation Analysis]
43 Kido A, Tsujiuchi T, Morishita T, Tsutsumi M, Takahama M, Miyauchi Y, Mii Y, Tamai S, Konishi Y. Telomerase activity correlates with growth of transplantable osteosarcomas in rats treated with cis-diammine dichloroplatinum or the angiogenesis inhibitor AGM-1470. Jpn J Cancer Res 1998;89:1074-81. [PMID: 9849588 DOI: 10.1111/j.1349-7006.1998.tb00499.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
44 Cantrell LA, Zhou C, Mendivil A, Malloy KM, Gehrig PA, Bae-Jump VL. Metformin is a potent inhibitor of endometrial cancer cell proliferation--implications for a novel treatment strategy. Gynecol Oncol 2010;116:92-8. [PMID: 19822355 DOI: 10.1016/j.ygyno.2009.09.024] [Cited by in Crossref: 222] [Cited by in F6Publishing: 210] [Article Influence: 17.1] [Reference Citation Analysis]
45 Liang L, Wang X, Xing D, Chen T, Chen WR. Noninvasive determination of cell nucleoplasmic viscosity by fluorescence correlation spectroscopy. J Biomed Opt 2009;14:024013. [PMID: 19405743 DOI: 10.1117/1.3088141] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
46 Murakami J, Nacai N, Ohama K. Telomerase Activity in Body Cavity Fluid and Peritoneal Washings in Uterine and Ovarian Cancer. J Int Med Res 1998;26:129-39. [DOI: 10.1177/030006059802600303] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
47 Sundararaj KP, Wood RE, Ponnusamy S, Salas AM, Szulc Z, Bielawska A, Obeid LM, Hannun YA, Ogretmen B. Rapid Shortening of Telomere Length in Response to Ceramide Involves the Inhibition of Telomere Binding Activity of Nuclear Glyceraldehyde-3-phosphate Dehydrogenase. Journal of Biological Chemistry 2004;279:6152-62. [DOI: 10.1074/jbc.m310549200] [Cited by in Crossref: 89] [Cited by in F6Publishing: 39] [Article Influence: 4.9] [Reference Citation Analysis]
48 Mor-Tzuntz R, Uziel O, Shpilberg O, Lahav J, Raanani P, Bakhanashvili M, Rabizadeh E, Zimra Y, Lahav M, Granot G. Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib. Exp Hematol 2010;38:27-37. [PMID: 19837126 DOI: 10.1016/j.exphem.2009.10.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
49 Shimada Y, Nakano M, Kanda N, Murakami-murofushi K, Kim JK, Ide T, Murofushi H. Cell Cycle-Dependent Activation of Telomerase in Naturally Synchronized Culture of a True Slime Mold,Physarum polycephalum. Biochemical and Biophysical Research Communications 1997;232:492-6. [DOI: 10.1006/bbrc.1997.6327] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
50 Bickenbach JR, Vormwald-dogan V, Bachor C, Bleuel K, Schnapp G, Boukamp P. Telomerase is Not an Epidermal Stem Cell Marker and is Downregulated by Calcium. Journal of Investigative Dermatology 1998;111:1045-52. [DOI: 10.1046/j.1523-1747.1998.00420.x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 2.3] [Reference Citation Analysis]
51 Jády BE, Richard P, Bertrand E, Kiss T. Cell cycle-dependent recruitment of telomerase RNA and Cajal bodies to human telomeres. Mol Biol Cell 2006;17:944-54. [PMID: 16319170 DOI: 10.1091/mbc.e05-09-0904] [Cited by in Crossref: 129] [Cited by in F6Publishing: 97] [Article Influence: 7.6] [Reference Citation Analysis]
52 Wang C, Zhao L, Lu S. Role of TERRA in the regulation of telomere length. Int J Biol Sci 2015;11:316-23. [PMID: 25678850 DOI: 10.7150/ijbs.10528] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 7.4] [Reference Citation Analysis]
53 Rudolph P, Schubert C, Tamm S, Heidorn K, Hauschild A, Michalska I, Majewski S, Krupp G, Jablonska S, Parwaresch R. Telomerase activity in melanocytic lesions: A potential marker of tumor biology. Am J Pathol 2000;156:1425-32. [PMID: 10751366 DOI: 10.1016/S0002-9440(10)65011-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
54 Hasan AS, Luo L, Baba S, Li TS. Estrogen is required for maintaining the quality of cardiac stem cells. PLoS One 2021;16:e0245166. [PMID: 33481861 DOI: 10.1371/journal.pone.0245166] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Pan C, Xue B, Ellis TM, Peace DJ, Dı́az MO. Changes in Telomerase Activity and Telomere Length during Human T Lymphocyte Senescence. Experimental Cell Research 1997;231:346-53. [DOI: 10.1006/excr.1997.3475] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 1.6] [Reference Citation Analysis]
56 Li L, Guan Y, Liu H, Hao N, Liu T, Meng X, Fu C, Li Y, Qu Q, Zhang Y, Ji S, Chen L, Chen D, Tang F. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano 2011;5:7462-70. [PMID: 21854047 DOI: 10.1021/nn202399w] [Cited by in Crossref: 196] [Cited by in F6Publishing: 197] [Article Influence: 17.8] [Reference Citation Analysis]
57 Chen Y, Kong QZ. Dynamic changes of telomerase reverse transcriptase and P53 in the development of rat hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2009; 17(15): 1493-1497 [DOI: 10.11569/wcjd.v17.i15.1493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Drummond MW, Balabanov S, Holyoake TL, Brummendorf TH. Concise review: Telomere biology in normal and leukemic hematopoietic stem cells. Stem Cells 2007;25:1853-61. [PMID: 17510216 DOI: 10.1634/stemcells.2007-0057] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.7] [Reference Citation Analysis]
59 Zou BQ, Qin QP, Bai YX, Cao QQ, Zhang Y, Liu YC, Chen ZF, Liang H. Synthesis and antitumor mechanism of a new iron(iii) complex with 5,7-dichloro-2-methyl-8-quinolinol as ligands. Medchemcomm 2017;8:633-9. [PMID: 30108780 DOI: 10.1039/c6md00644b] [Cited by in Crossref: 15] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
60 Seol JG, Kim ES, Park WH, Jung CW, Kim BK, Lee YY. Telomerase activity in acute myelogenous leukaemia: clinical and biological implications. Br J Haematol. 1998;100:156-165. [PMID: 9450805 DOI: 10.1046/j.1365-2141.1998.00524.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.6] [Reference Citation Analysis]
61 Harvat B, Jetten AM. Growth Control by Retinoids: Regulation of Cell Cycle Progression and Apoptosis. In: Nau H, Blaner WS, editors. Retinoids. Berlin: Springer Berlin Heidelberg; 1999. pp. 239-76. [DOI: 10.1007/978-3-642-58483-1_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
62 Chen P, Liu B, Hu M. The effect of hydroxycamptothecin and pingyangmycin on human squamous cell carcinoma of the tongue. Oncol Lett 2013;5:947-52. [PMID: 23426884 DOI: 10.3892/ol.2013.1109] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
63 Lindkvist A, Ivarsson K, Jernberg-Wiklund H, Paulsson-Karlsson Y. Interferon-induced sensitization to apoptosis is associated with repressed transcriptional activity of the hTERT promoter in multiple myeloma. Biochem Biophys Res Commun 2006;341:1141-8. [PMID: 16460686 DOI: 10.1016/j.bbrc.2006.01.068] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
64 Ramakrishnan S, Sharma HW, Farris AD, Kaufman KM, Harley JB, Collins K, Pruijn GJ, van Venrooij WJ, Martin ML, Narayanan R. Characterization of human telomerase complex. Proc Natl Acad Sci USA. 1997;94:10075-10079. [PMID: 9294165 DOI: 10.1073/pnas.94.19.10075] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
65 Xi L, Cech TR. Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT. Nucleic Acids Res 2014;42:8565-77. [PMID: 24990373 DOI: 10.1093/nar/gku560] [Cited by in Crossref: 93] [Cited by in F6Publishing: 84] [Article Influence: 11.6] [Reference Citation Analysis]
66 Leri A, Barlucchi L, Limana F, Deptala A, Darzynkiewicz Z, Hintze TH, Kajstura J, Nadal-Ginard B, Anversa P. Telomerase expression and activity are coupled with myocyte proliferation and preservation of telomeric length in the failing heart. Proc Natl Acad Sci USA. 2001;98:8626-8631. [PMID: 11447262 DOI: 10.1073/pnas.151013298] [Cited by in Crossref: 71] [Cited by in F6Publishing: 62] [Article Influence: 3.4] [Reference Citation Analysis]
67 Kallakury BV, Brien TP, Lowry CV, Muraca PJ, Fisher HA, Kaufman RP, Ross JS. Telomerase Activity in Human Benign Prostate Tissue and Prostatic Adenocarcinomas: . Diagnostic Molecular Pathology 1997;6:192-8. [DOI: 10.1097/00019606-199708000-00003] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
68 Ely SA, Chadburn A, Dayton CM, Cesarman E, Knowles DM. Telomerase activity in B-cell non-Hodgkin lymphoma. Cancer 2000;89:445-52. [DOI: 10.1002/1097-0142(20000715)89:2<445::aid-cncr33>3.0.co;2-t] [Cited by in Crossref: 23] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
69 Klapper W, Singh KK, Heidorn K, Parwaresch R, Krupp G. Regulation of telomerase activity in quiescent immortalized human cells. Biochim Biophys Acta 1998;1442:120-6. [PMID: 9804918 DOI: 10.1016/s0167-4781(98)00155-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
70 Tamura K, Liu H, Takahashi H. Auxin Induction of Cell Cycle Regulated Activity of Tobacco Telomerase. Journal of Biological Chemistry 1999;274:20997-1002. [DOI: 10.1074/jbc.274.30.20997] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
71 Liu W, Jiang J, Xiao D, Ding J. Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochemical Pharmacology 2002;64:1677-87. [DOI: 10.1016/s0006-2952(02)01424-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
72 Yamada O, Ozaki K, Nakatake M, Akiyama M, Kawauchi K, Matsuoka R. Multistep regulation of telomerase during differentiation of HL60 cells. Journal of Leukocyte Biology 2008;83:1240-8. [DOI: 10.1189/jlb.1207848] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
73 Qin QP, Wang SL, Tan MX, Wang ZF, Luo DM, Zou BQ, Liu YC, Yao PF, Liang H. Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway. Eur J Med Chem 2018;158:106-22. [PMID: 30205260 DOI: 10.1016/j.ejmech.2018.09.008] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
74 Lichtsteiner SP, Lebkowski JS, Vasserot AP. Telomerase. A target for anticancer therapy. Ann N Y Acad Sci. 1999;886:1-11. [PMID: 10667198 DOI: 10.1111/j.1749-6632.1999.tb09395.x] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
75 Vega F, Davuluri Y, Cho-Vega JH, Singh RR, Ma S, Wang RY, Multani AS, Drakos E, Pham LV, Lee YC, Shen L, Ambrus J Jr, Medeiros LJ, Ford RJ. Side population of a murine mantle cell lymphoma model contains tumour-initiating cells responsible for lymphoma maintenance and dissemination. J Cell Mol Med 2010;14:1532-45. [PMID: 19656242 DOI: 10.1111/j.1582-4934.2009.00865.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
76 Ballon G, Trentin L, Rossi AD, Semenzato G. Telomerase Activity and Clinical Progression in Chronic Lymphoproliferative Disorders of B-Cell Lineage. Leukemia & Lymphoma 2009;41:35-45. [DOI: 10.3109/10428190109057952] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
77 Kunisada M, Budiyanto A, Bito T, Nishigori C, Ueda M. Retinoic acid suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma. Br J Dermatol 2005;152:435-43. [DOI: 10.1111/j.1365-2133.2005.06471x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
78 Katakura Y, Nakata E, Miura T, Shirahata S. Transforming Growth Factor β Triggers Two Independent-Senescence Programs in Cancer Cells. Biochemical and Biophysical Research Communications 1999;255:110-5. [DOI: 10.1006/bbrc.1999.0129] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 3.5] [Reference Citation Analysis]
79 Holt SE, Shay JW. Role of telomerase in cellular proliferation and cancer. J Cell Physiol 1999;180:10-8. [PMID: 10362013 DOI: 10.1002/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D] [Cited by in Crossref: 145] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
80 Tsujiuchi T, Tsutsumi M, Kido A, Takahama M, Sakitani H, Iki K, Sasaki Y, Denda A, Konishi Y. Induction of telomerase activity during regeneration after partial hepatectomy in the rat. Cancer Letters 1998;122:115-20. [DOI: 10.1016/s0304-3835(97)00378-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
81 Yang SW, Jin E, Chung IK, Kim WT. Cell cycle‐dependent regulation of telomerase activity by auxin, abscisic acid and protein phosphorylation in tobacco BY‐2 suspension culture cells. The Plant Journal 2002;29:617-26. [DOI: 10.1046/j.0960-7412.2001.01244.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
82 Majone F, Luisetto R, Zamboni D, Iwanaga Y, Jeang KT. Ku protein as a potential human T-cell leukemia virus type 1 (HTLV-1) Tax target in clastogenic chromosomal instability of mammalian cells. Retrovirology 2005;2:45. [PMID: 16014171 DOI: 10.1186/1742-4690-2-45] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
83 Rossi A, Russo G, Puca A, La Montagna R, Caputo M, Mattioli E, Lopez M, Giordano A, Pentimalli F. The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. Int J Cancer 2009;125:235-43. [PMID: 19358275 DOI: 10.1002/ijc.24331] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
84 Albanell J, Engelhardt M, Han W, Moore MAS, Lonardo F, Rusch V, Langenfeld J, Klimstra D, Venkatraman E, Dmitrovsky E. High Telomerase Activity in Primary Lung Cancers: Association With Increased Cell Proliferation Rates and Advanced Pathologic Stage. JNCI Journal of the National Cancer Institute 1997;89:1609-15. [DOI: 10.1093/jnci/89.21.1609] [Cited by in Crossref: 138] [Cited by in F6Publishing: 114] [Article Influence: 5.5] [Reference Citation Analysis]
85 Li J, Mansmann UR. A molecular signaling map and its application. Cell Signal 2014;26:2834-42. [PMID: 25192909 DOI: 10.1016/j.cellsig.2014.08.022] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
86 Nakatake M, Sasaki N, Murakami-Murofushi K, Yamada O. Transient posttranslational up-regulation of telomerase activity during megakaryocytic differentiation of K562 cells. Biochem Biophys Res Commun 2004;314:1080-5. [PMID: 14751243 DOI: 10.1016/j.bbrc.2003.12.199] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
87 Robertson JD, Gale RE, Wynn RF, Dougal M, Linch DC, Testa NG, Chopra R. Dynamics of telomere shortening in neutrophils and T lymphocytes during ageing and the relationship to skewed X chromosome inactivation patterns. Br J Haematol 2000;109:272-9. [PMID: 10848812 DOI: 10.1046/j.1365-2141.2000.01970.x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 69] [Article Influence: 3.2] [Reference Citation Analysis]
88 Yokoyama Y, Takahashi Y, Shinohara A, Lian Z, Tamaya T. Telomerase activity in the female reproductive tract and neoplasms. Gynecol Oncol 1998;68:145-9. [PMID: 9514809 DOI: 10.1006/gyno.1997.4921] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
89 Wu X, Wu J, Dai J, Chen B, Chen Z, Wang S, Wu F, Lou X, Xia F. Aggregation-induced emission luminogens reveal cell cycle-dependent telomerase activity in cancer cells. National Science Review 2021;8:nwaa306. [DOI: 10.1093/nsr/nwaa306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
90 Taji F, Kouchesfahani HM, Sheikholeslami F, Romani B, Baesi K, Vahabpour R, Edalati M, Teimoori-Toolabi L, Jazaeri EO, Abdoli A. Autophagy induction reduces telomerase activity in HeLa cells. Mech Ageing Dev 2017;163:40-5. [PMID: 28043814 DOI: 10.1016/j.mad.2016.12.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
91 Igarashi H, Sakaguchi N. Telomerase Activity Is Induced in Human Peripheral B Lymphocytes by the Stimulation to Antigen Receptor. Blood 1997;89:1299-307. [DOI: 10.1182/blood.v89.4.1299] [Cited by in Crossref: 74] [Article Influence: 3.0] [Reference Citation Analysis]
92 Bryan TM, Marusic L, Bacchetti S, Namba M, Reddel RR. The telomere lengthening mechanism in telomerase-negative immortal human cells does not involve the telomerase RNA subunit. Hum Mol Genet 1997;6:921-6. [PMID: 9175740 DOI: 10.1093/hmg/6.6.921] [Cited by in Crossref: 125] [Cited by in F6Publishing: 118] [Article Influence: 5.0] [Reference Citation Analysis]
93 Senthilkumar PK, Klingelhutz AJ, Jacobus JA, Lehmler H, Robertson LW, Ludewig G. Airborne polychlorinated biphenyls (PCBs) reduce telomerase activity and shorten telomere length in immortal human skin keratinocytes (HaCat). Toxicol Lett. 2011;204:64-70. [PMID: 21530622 DOI: 10.1016/j.toxlet.2011.04.012] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
94 Kondo S, Tanaka Y, Kondo Y, Hitomi M, Barnett GH, Ishizaka Y, Liu J, Haqqi T, Nishiyama A, Villeponteau B, Cowell JK, Barna BP. Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation. FASEB J 1998;12:801-11. [PMID: 9657520 DOI: 10.1096/fasebj.12.10.801] [Cited by in Crossref: 123] [Cited by in F6Publishing: 113] [Article Influence: 5.1] [Reference Citation Analysis]
95 Gao J, Chen D, Tian Y, Zhang J, Cai K. Effect of estrogen on telomerase activity in human breast cancer cells. J Huazhong Univ Sci Technolog Med Sci 2003;23:286-7, 293. [PMID: 14526436 DOI: 10.1007/BF02829516] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
96 Zhang RG, Guo LX, Wang XW, Xie H. Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin. World J Gastroenterol 2002; 8(5): 827-831 [PMID: 12378624 DOI: 10.3748/wjg.v8.i5.827] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
97 Fu XH, Zhang JS, Zhang N, Zhang YD. Combination of telomerase antisense oligonucleotides simultaneously targeting hTR and hTERT produces synergism of inhibition of telomerase activity and growth in human colon cancer cell line. World J Gastroenterol 2005; 11(6): 785-790 [PMID: 15682468 DOI: 10.3748/wjg.v11.i6.785] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
98 Marusíc L, Anton M, Tidy A, Wang P, Villeponteau B, Bacchetti S. Reprogramming of telomerase by expression of mutant telomerase RNA template in human cells leads to altered telomeres that correlate with reduced cell viability. Mol Cell Biol 1997;17:6394-401. [PMID: 9343401 DOI: 10.1128/MCB.17.11.6394] [Cited by in Crossref: 54] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
99 Scheel C, Schaefer K, Jauch A, Keller M, Wai D, Brinkschmidt C, van Valen F, Boecker W, Dockhorn-dworniczak B, Poremba C. Alternative lengthening of telomeres is associated with chromosomal instability in osteosarcomas. Oncogene 2001;20:3835-44. [DOI: 10.1038/sj.onc.1204493] [Cited by in Crossref: 121] [Cited by in F6Publishing: 105] [Article Influence: 5.8] [Reference Citation Analysis]
100 Yang Y, Sun H, Zhou Y, Ji S, Li M. Effects of three diterpenoids on tumour cell proliferation and telomerase activity. Natural Product Research 2009;23:1007-12. [DOI: 10.1080/14786410802295149] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
101 Coffman FD, Studzinski GP. Differentiation-related mechanisms which suppress DNA replication. Exp Cell Res 1999;248:58-73. [PMID: 10094813 DOI: 10.1006/excr.1999.4457] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 2.0] [Reference Citation Analysis]
102 Vogan JM, Collins K. Dynamics of Human Telomerase Holoenzyme Assembly and Subunit Exchange across the Cell Cycle. J Biol Chem 2015;290:21320-35. [PMID: 26170453 DOI: 10.1074/jbc.M115.659359] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
103 Almami A, Hegazy SA, Nabbi A, Alshalalfa M, Salman A, Abou-Ouf H, Riabowol K, Bismar TA. ING3 is associated with increased cell invasion and lethal outcome in ERG-negative prostate cancer patients. Tumour Biol 2016;37:9731-8. [PMID: 26803516 DOI: 10.1007/s13277-016-4802-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
104 Mehta IS, Figgitt M, Clements CS, Kill IR, Bridger JM. Alterations to nuclear architecture and genome behavior in senescent cells. Ann N Y Acad Sci 2007;1100:250-63. [PMID: 17460187 DOI: 10.1196/annals.1395.027] [Cited by in Crossref: 64] [Cited by in F6Publishing: 59] [Article Influence: 4.3] [Reference Citation Analysis]
105 Zimmermann S, Martens UM. Telomeres, senescence, and hematopoietic stem cells. Cell Tissue Res 2008;331:79-90. [PMID: 17960423 DOI: 10.1007/s00441-007-0469-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.3] [Reference Citation Analysis]
106 Ševčíková T, Bišová K, Fojtová M, Lukešová A, Hrčková K, Sýkorová E. Completion of cell division is associated with maximum telomerase activity in naturally synchronized cultures of the green alga Desmodesmus quadricauda. FEBS Lett 2013;587:743-8. [PMID: 23395610 DOI: 10.1016/j.febslet.2013.01.058] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
107 Zhang LP, Jiang JK, Tam JW, Zhang Y, Liu XS, Xu XR, Liu BZ, He YJ. Effects of Matrine on proliferation and differentiation in K-562 cells. Leuk Res. 2001;25:793-800. [PMID: 11489473 DOI: 10.1016/s0145-2126(00)00145-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
108 Budiyanto A, Bito T, Kunisada M, Ashida M, Ichihashi M, Ueda M. Inhibition of the epidermal growth factor receptor suppresses telomerase activity in HSC-1 human cutaneous squamous cell carcinoma cells. J Invest Dermatol 2003;121:1088-94. [PMID: 14708611 DOI: 10.1046/j.1523-1747.2003.12529.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
109 Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells. Blood 1997;90:182-93. [DOI: 10.1182/blood.v90.1.182] [Cited by in Crossref: 189] [Article Influence: 7.6] [Reference Citation Analysis]
110 Ishikawa T, Kamiyama M, Hisatomi H, Ichikawa Y, Momiyama N, Hamaguchi Y, Hasegawa S, Narita T, Shimada H. Telomerase enzyme activity and RNA expression in adriamycin-resistant human breast carcinoma MCF-7 cells. Cancer Lett. 1999;141:187-194. [PMID: 10454261 DOI: 10.1016/s0304-3835(99)00103-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
111 Qin J, Qin Q, Wei Z, Yu Y, Meng T, Wu C, Liang Y, Liang H, Chen Z. Stabilization of c-myc G-Quadruplex DNA, inhibition of telomerase activity, disruption of mitochondrial functions and tumor cell apoptosis by platinum(II) complex with 9-amino-oxoisoaporphine. European Journal of Medicinal Chemistry 2016;124:417-27. [DOI: 10.1016/j.ejmech.2016.08.054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
112 Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Eur J Surg Oncol. 2002;28:225-234. [PMID: 11944954 DOI: 10.1053/ejso.2001.1237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
113 Shapira S, Granot G, Mor-Tzuntz R, Raanani P, Uziel O, Lahav M, Shpilberg O. Second-generation tyrosine kinase inhibitors reduce telomerase activity in K562 cells. Cancer Lett 2012;323:223-31. [PMID: 22554713 DOI: 10.1016/j.canlet.2012.04.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
114 Kyo S, Inoue M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: how can we apply them for cancer therapy? Oncogene. 2002;21:688-697. [PMID: 11850797 DOI: 10.1038/sj.onc.1205163] [Cited by in Crossref: 123] [Cited by in F6Publishing: 105] [Article Influence: 6.2] [Reference Citation Analysis]
115 Elenitoba-Johnson KS. Complex regulation of telomerase activity: implications for cancer therapy. Am J Pathol 2001;159:405-10. [PMID: 11485897 DOI: 10.1016/S0002-9440(10)61710-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
116 Noureen N, Wu S, Lv Y, Yang J, Alfred Yung WK, Gelfond J, Wang X, Koul D, Ludlow A, Zheng S. Integrated analysis of telomerase enzymatic activity unravels an association with cancer stemness and proliferation. Nat Commun 2021;12:139. [PMID: 33420056 DOI: 10.1038/s41467-020-20474-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
117 Bellon M, Nicot C. Central role of PI3K in transcriptional activation of hTERT in HTLV-I-infected cells. Blood 2008;112:2946-55. [PMID: 18511807 DOI: 10.1182/blood-2008-01-134692] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 2.5] [Reference Citation Analysis]
118 Kim JH, Park DC, Kim JW, Choi YK, Lew YO, Kim DH, Jung JK, Lim YA, Namkoong SE. Antitumor Effect of GnRH Agonist in Epithelial Ovarian Cancer. Gynecologic Oncology 1999;74:170-80. [DOI: 10.1006/gyno.1999.5413] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
119 Yokoyama Y, Takahashi Y, Morishita S, Hashimoto M, Tamaya T. Introduction of p21(Waf1/Cip1) gene into a carcinoma cell line of the uterine cervix with inactivated p53. Cancer Lett 1997;116:233-9. [PMID: 9215868 DOI: 10.1016/s0304-3835(97)00193-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
120 Lee JH, Lee SY, Lee JH, Lee SH. p21 WAF1 is involved in interferon-β-induced attenuation of telomerase activity and human telomerase reverse transcriptase (hTERT) expression in ovarian cancer. Mol Cells 2010;30:327-33. [PMID: 20814747 DOI: 10.1007/s10059-010-0131-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
121 Finnon P, Silver AR, Bouffler SD. Upregulation of telomerase activity by X-irradiation in mouse leukaemia cells is independent of Tert, Terc, Tnks and Myc transcription. Carcinogenesis 2000;21:573-8. [PMID: 10753188 DOI: 10.1093/carcin/21.4.573] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
122 Zhou JH, Zhang HM, Chen Q, Han DD, Pei F, Zhang LS, Yang DT. Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma. World J Gastroenterol 2003; 9(8): 1808-1814 [PMID: 12918126 DOI: 10.3748/wjg.v9.i8.1808] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
123 Reichman TW, Albanell J, Wang X, Moore MA, Studzinski GP. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem 1997;67:13-23. [DOI: 10.1002/(sici)1097-4644(19971001)67:1<13::aid-jcb2>3.0.co;2-z] [Cited by in Crossref: 28] [Article Influence: 1.1] [Reference Citation Analysis]
124 Maddula S, Baumbach JI. Heterogeneity in tumor cell energetic metabolome at different cell cycle phases of human colon cancer cell lines. Metabolomics 2011;7:509-23. [DOI: 10.1007/s11306-010-0267-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
125 Elwood NJ. Telomere Biology of Human Hematopoietic Stem Cells. Cancer Control 2017;11:77-85. [DOI: 10.1177/107327480401100214] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
126 Ji X, Chen J, Sun H, Zhou H, Xiang J, Peng A, Tang Y, Zhao C. The interaction of telomere DNA G-quadruplex with three bis-benzyltetrahydroisoquinoline alkaloids. Nucleic Acid Ther 2011;21:415-22. [PMID: 22017543 DOI: 10.1089/nat.2011.0311] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
127 Nakamura M, Saito H, Ebinuma H, Wakabayashi K, Saito Y, Takagi T, Nakamoto N, Ishii H. Reduction of telomerase activity in human liver cancer cells by a histone deacetylase inhibitor. J Cell Physiol 2001;187:392-401. [DOI: 10.1002/jcp.1087] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
128 Jain RK, Hong DS, Naing A, Wheler J, Helgason T, Shi NY, Gad Y, Kurzrock R. Novel phase I study combining G1 phase, S phase, and G2/M phase cell cycle inhibitors in patients with advanced malignancies. Cell Cycle 2015;14:3434-40. [PMID: 26467427 DOI: 10.1080/15384101.2015.1090065] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
129 Haïk S, Gauthier LR, Granotier C, Peyrin JM, Lages CS, Dormont D, Boussin FD. Fibroblast growth factor 2 up regulates telomerase activity in neural precursor cells. Oncogene 2000;19:2957-66. [PMID: 10871847 DOI: 10.1038/sj.onc.1203596] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 2.1] [Reference Citation Analysis]
130 Alibardi L. Immunolocalization of the telomerase‐1 component in cells of the regenerating tail, testis, and intestine of lizards. Journal of Morphology 2015;276:748-58. [DOI: 10.1002/jmor.20375] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.9] [Reference Citation Analysis]
131 Wei ZZ, Qin QP, Chen JN, Chen ZF. Oxoisoaporphine as Potent Telomerase Inhibitor. Molecules 2016;21:E1534. [PMID: 27854257 DOI: 10.3390/molecules21111534] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
132 Hyeon Joo O, Hande MP, Lansdorp PM, Natarajan AT. Induction of telomerase activity and chromosome aberrations in human tumour cell lines following X-irradiation. Mutat Res 1998;401:121-31. [PMID: 9639690 DOI: 10.1016/s0027-5107(97)00321-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
133 Fu J, Wang D, Mei D, Zhang H, Wang Z, He B, Dai W, Zhang H, Wang X, Zhang Q. Macrophage mediated biomimetic delivery system for the treatment of lung metastasis of breast cancer. Journal of Controlled Release 2015;204:11-9. [DOI: 10.1016/j.jconrel.2015.01.039] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 8.4] [Reference Citation Analysis]
134 Dhaene K, Vancoillie G, Lambert J, Naeyaert JM, Van Marck E. Absence of telomerase activity and telemorase catalytic subunit mRNA in melanocyte cultures. Br J Cancer 2000;82:1051-7. [PMID: 10737388 DOI: 10.1054/bjoc.1999.1041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
135 Petrov VV, van Pelt JF, Vermeesch JR, Van Duppen VJ, Vekemans K, Fagard RH, Lijnen PJ. TGF-beta1-induced cardiac myofibroblasts are nonproliferating functional cells carrying DNA damages. Exp Cell Res 2008;314:1480-94. [PMID: 18295203 DOI: 10.1016/j.yexcr.2008.01.014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
136 Masutomi K, Yu EY, Khurts S, Ben-Porath I, Currier JL, Metz GB, Brooks MW, Kaneko S, Murakami S, DeCaprio JA. Telomerase maintains telomere structure in normal human cells. Cell. 2003;114:241-253. [PMID: 12887925 DOI: 10.1016/s0092-8674(03)00550-6] [Cited by in Crossref: 523] [Cited by in F6Publishing: 171] [Article Influence: 27.5] [Reference Citation Analysis]
137 Kajstura J, Leri A, Castaldo C, Nadal-Ginard B, Anversa P. Myocyte growth in the failing heart. Surg Clin North Am 2004;84:161-77. [PMID: 15053188 DOI: 10.1016/S0039-6109(03)00215-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
138 Yang D, Liu L, Zheng X. Cyclin-dependent kinase inhibitor p16INK4a and telomerase may co-modulate endothelial progenitor cells senescence. Ageing Research Reviews 2008;7:137-46. [DOI: 10.1016/j.arr.2008.02.001] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
139 Akiyama M, Iwase S, Horiguchi-yamada J, Saito S, Furukawa Y, Yamada O, Mizoguchi H, Ohno T, Yamada H. Interferon-α repressed telomerase along with G1-accumulation of Daudi cells. Cancer Letters 1999;142:23-30. [DOI: 10.1016/s0304-3835(99)00109-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
140 Boltze C, Schneider-Stock R, Roessner A, Quednow C, Hoang-Vu C. Function of HSP90 and p23 in the telomerasecomplex of thyroid tumors. Pathol Res Pract. 2003;199:573-579. [PMID: 14621192 DOI: 10.1078/0344-0338-00464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
141 Wen J, Wang L, Zhang M, Xie D, Sun L. Repression of Telomerase Activity During In Vitro Differentiation of Osteosarcoma Cells. Cancer Investigation 2002;20:38-45. [DOI: 10.1081/cnv-120000364] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
142 Janknecht R. On the road to immortality: hTERT upregulation in cancer cells. FEBS Lett. 2004;564:9-13. [PMID: 15094035 DOI: 10.1016/s0014-5793(04)00356-4] [Cited by in Crossref: 85] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
143 Engelhardt M, Kumar R, Albanell J, Pettengell R, Han W, Moore MA. Telomerase Regulation, Cell Cycle, and Telomere Stability in Primitive Hematopoietic Cells. Blood 1997;90:182-93. [DOI: 10.1182/blood.v90.1.182.182_182_193] [Cited by in Crossref: 16] [Article Influence: 0.6] [Reference Citation Analysis]
144 Zhang RG, Zhang RP, Wang XW, Xie H. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells. Cell Res 2002;12:55-62. [PMID: 11942411 DOI: 10.1038/sj.cr.7290110] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
145 Nicosia SV, Bai W, Cheng JQ, Coppola D, Kruk PA. Oncogenic pathways implicated in ovarian epithelial cancer. Hematol Oncol Clin North Am 2003;17:927-43. [PMID: 12959183 DOI: 10.1016/s0889-8588(03)00056-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
146 Vietor M, Winter S, Groscurth P, Naumann U, Weller M. On the significance of telomerase activity in human malignant glioma cells. Eur J Pharmacol 2000;407:27-37. [PMID: 11050287 DOI: 10.1016/s0014-2999(00)00726-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
147 Schmidt JC, Cech TR. Human telomerase: biogenesis, trafficking, recruitment, and activation. Genes Dev 2015;29:1095-105. [PMID: 26063571 DOI: 10.1101/gad.263863.115] [Cited by in Crossref: 170] [Cited by in F6Publishing: 155] [Article Influence: 24.3] [Reference Citation Analysis]
148 Holt SE, Aisner DL, Shay JW, Wright WE. Lack of cell cycle regulation of telomerase activity in human cells. Proc Natl Acad Sci USA. 1997;94:10687-10692. [PMID: 9380696 DOI: 10.1073/pnas.94.20.10687] [Cited by in Crossref: 101] [Cited by in F6Publishing: 107] [Article Influence: 4.0] [Reference Citation Analysis]
149 Qu Y, Wang Z, Huang X, Wan C, Yang C, Liu B, Cornelissen G, Halberg F. Circadian telomerase activity and DNA synthesis for timing peptide administration. Peptides 2003;24:363-9. [DOI: 10.1016/s0196-9781(03)00050-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
150 Li K, Zhang J, Ren JJ, Wang Q, Yang KY, Xiong ZJ, Mao YQ, Qi YY, Chen XW, Lan F, Wang XJ, Xiao HY, Lin P, Wei YQ. A novel zinc finger protein Zfp637 behaves as a repressive regulator in myogenic cellular differentiation. J Cell Biochem 2010;110:352-62. [PMID: 20235149 DOI: 10.1002/jcb.22546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 0.1] [Reference Citation Analysis]
151 Richardson GD, Breault D, Horrocks G, Cormack S, Hole N, Owens WA. Telomerase expression in the mammalian heart. FASEB J 2012;26:4832-40. [PMID: 22919071 DOI: 10.1096/fj.12-208843] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.7] [Reference Citation Analysis]
152 Thurnher D, Knerer B, Formanek M, Kornfehl J. Non-radioactive semiquantitative testing for the expression levels of telomerase activity in head and neck squamous cell carcinomas may be indicative for biological tumour behaviour. Acta Otolaryngol 1998;118:423-7. [PMID: 9655221 DOI: 10.1080/00016489850183557] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
153 Kitao S, Ohsugi I, Ichikawa K, Goto M, Furuichi Y, Shimamoto A. Cloning of Two New Human Helicase Genes of the RecQ Family: Biological Significance of Multiple Species in Higher Eukaryotes. Genomics 1998;54:443-52. [DOI: 10.1006/geno.1998.5595] [Cited by in Crossref: 174] [Cited by in F6Publishing: 176] [Article Influence: 7.3] [Reference Citation Analysis]
154 Ogawa D, Nomiyama T, Nakamachi T, Heywood EB, Stone JF, Berger JP, Law RE, Bruemmer D. Activation of peroxisome proliferator-activated receptor gamma suppresses telomerase activity in vascular smooth muscle cells. Circ Res 2006;98:e50-9. [PMID: 16556873 DOI: 10.1161/01.RES.0000218271.93076.c3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 33] [Article Influence: 3.8] [Reference Citation Analysis]
155 Gelmini S, Caldini A, Becherini L, Capaccioli S, Pazzagli M, Orlando C. Rapid, quantitative nonisotopic assay for telomerase activity in human tumors. Clinical Chemistry 1998;44:2133-8. [DOI: 10.1093/clinchem/44.10.2133] [Cited by in Crossref: 47] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]